Uniting biological toolkits for a new approach to ALS
Google DeepMind
Ritu Raman and Ryan Flynn are collaborating on ALS research by combining their separate expertise in tissue engineering and RNA biology, facilitated by an AI tool called Co-Scientist. Co-Scientist helped Raman rapidly synthesize months of fragmented ALS literature and generate testable hypotheses for her tissue models within weeks. Their combined approach now targets RNA-based mechanisms at cell surfaces as potential therapeutic avenues for ALS.
Why it matters
Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
